Asthma and COVID-19: lessons learned and questions that remain.

Daniel HowellHannah VermaKam Sing HoBharat NarasimhanDavid SteigerLinda Rogers

Published in: Expert review of respiratory medicine (2021)

Asthma diagnosis may be a risk factor for severe COVID-19 especially for those with severe disease or nonallergic phenotypes. COVID-19 does not appear to provoke asthma exacerbations and asthma therapeutics should be continued for patients with exposure to COVID-19. Clearly much regarding this topic remains unknown and we identify some key questions that may be of interest for future researchers.[Figure: see text].

Keyphrases

coronavirus disease
chronic obstructive pulmonary disease
sars cov
lung function
allergic rhinitis
respiratory syndrome coronavirus
cystic fibrosis
early onset
small molecule
smoking cessation
air pollution